Home ••• Newswires by Industry • Countries • U.S. States • World Media Directory

Pharmaceutical Industry News ••• Topics • Countries • U.S. States

Cyclophosphamide News Monitoring

Get by Email • RSS

Published on 01:55 GMT

FDA Grants Azer-Cel Fast Track Status in DLBCL

The FDA granted fast track designation to azercabtagene zapreleucel (azer-cel; PBCAR0191) for the treatment of patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL). Azer-cel is an allogeneic chimeric antigen receptor (CAR) T-cell …

Source: Targeted Oncology - Label Pending
Published on Mar 24, 2025

Early cardiotoxicity in post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis after HLA-...

Toshihiro Matsukawa Department of Hematology, Faculty of Medicine, Graduate School of Medicine, Hokkaido University, Kita 15, Nishi 7, Kita-ku, Sapporo, 0608638, Japan. toshimatsukawa@med.hokudai.ac.jp. Junichi Sugita Department of Hematology, Sapporo …

Source: Physician's Weekly - Neutral
Published on Mar 23, 2025

The Targeted Pulse: Excellent Advancements in Breast Cancer Management and an Extended Access Program for NMIBC

TMLI Plus Post-Transplant Cyclophosphamide Improves Transplant Outcomes in AML Administering total marrow and lymphoid irradiation at 20 Gy alongside post-transplant cyclophosphamide improved outcomes for patients with acute myeloid leukemia undergoing …

Source: Targeted Oncology - Label Pending
Published on Mar 21, 2025

FDA Grants Fast Track Designation for Azer-Cel in Lymphoma Subset

The U.S. Food and Drug Administration (FDA) has granted fast track designation to the allogenic CAR T-cell therapy azer-cel (azercabtagene zapreleucel) for the treatment of patients with relapsed or refractory diffuse large B-cell lymphoma, according to …

Source: Cure Today - Neutral
Published on Mar 21, 2025

Human medicines European public assessment report (EPAR): Polivy, polatuzumab vedotin, Date of authorisation: 16/01/2020,...

Polivy can affect the production of blood cells. The most common side effects of Polivy in combination with rituximab, cyclophosphamide, doxorubicin and prednisone (which may affect more than 3 in 10 people) are peripheral neuropathy, nausea (feeling sick …

Source: European Medicines Agency - Label Pending
Published on Mar 24, 2025

Global Anaplastic Large Cell Lymphoma Therapeutics Market: Key Trends, Market Share, Growth, and Forecast for 2025-2034

The Business Research Company’s Anaplastic Large Cell Lymphoma Therapeutics Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, March 24, 2025 /⁨EINPresswire.com⁩/ -- Can targeted …

Distribution channels: Business & Economy, Chemical Industry ...
Published on Mar 21, 2025

Childhood cancer survivors undergo increased risk of melanoma: ASCO Study

A new study published in the Journal of Clinical Oncology found that childhood cancer survivors have a more than twofold increased risk of developing melanoma when compared to the general population. Although it has long been recognized that children who …

Source: Medical Dialogues - Uncategorized
Published on Mar 20, 2025

Golidocitinib Plus PD-1 Antibodies Being Explored in Lung Cancer Subset

Among patients with non-small cell lung cancer (NSCLC), treatment with the Janus kinase 1 (JAK1)-only inhibitor golidocitinib with PD-1 antibodies following progression on anti-PD-1 therapy elicited responses in 44.3% of patients. New findings on …

Source: Cure Today - Neutral
Published on Mar 20, 2025

FDA Grants Fast Track Designation to Azer-Cel for R/R DLBCL

The FDA has granted fast track designation to the allogeneic CAR T-cell therapy azercabtagene zapreleucel (azer-cel; PBCAR0191) as a potential therapeutic option for patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL).1 The off-the- …

Source: OncLive - Label Pending
Published on Mar 20, 2025

Haploidentical Transplants with Low-Dose ATG and PTCy Improve Outcomes in Older Patients

Photo Credit: MTStock The following is a summary of “Improved survival in older patients with myeloid malignancies undergoing haploidentical peripheral blood stem cell transplantation with low-dose anti-thymocyte globin (ATG)/post-cyclophosphamide ( …

Source: Physician's Weekly - Neutral
Published on Mar 24, 2025

Complement 3 Glomerulopathy: 5 Differentials to Know

Complement 3 glomerulopathy (C3G) is a rare kidney disease characterized by abnormal complement regulation, leading to excessive deposition of complement protein C3 in the glomeruli. This condition often progresses to end-stage kidney disease. C3G commonly …

Source: Medscape - Neutral
Published on Mar 24, 2025

Novel regimen reduces chronic GVHD after allogeneic stem cell transplantation

March 24, 2025 2 min read Add topic to email alerts Subscribe We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Key takeaways: The addition of post …

Source: Healio News - Neutral
Published on Mar 23, 2025

Physical Functioning Measures May Predict Survival Outcomes, ICANS Risk With CAR T-Cell Therapy in NHL

Physical Functioning Measures With CAR T-Cell Therapy in NHL | Image Credit: © LASZLO– stock.adobe.com Adverse physical performance measures were associated with worse overall survival (OS) and a greater risk of developing immune effector cell–associated …

Source: OncLive - Label Pending
Published on Mar 20, 2025

Allo-SCT, Myeloablative Conditioning With Busulfan/Fludarabine Improves Survival in Myelofibrosis

Patients with myelofibrosis (MF) who underwent allogeneic-stem cell transplantation (allo-SCT) from matched donors using busulfan and fludarabine (BuFlu) myeloablative conditioning (MAC) in conjunction with thiotepa and posttransplant cyclophosphamide ( …

Source: Pharmacy Times - Neutral
Published on Mar 20, 2025

Episode 2: New Guidelines and the Lupus Nephritis Kidney Conundrum

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Maureen McMahon, MD: Hello. I'm Dr Maureen McMahon. Welcome to the …

Source: Medscape - Neutral
Published on Mar 20, 2025

HLA Typing For HSCT: New Research Indicates Expanded Patient Compatibility

By Selena Yu, GlobalData Human leukocyte antigen (HLA) typing is a molecular diagnostic tool important for understanding immune compatibility, which is used in hematopoietic stem cell transplantation (HSCT). HSCTs can occur with bone marrow, peripheral …

Source: Cell & Gene - Label Pending

06 days 16:08:53

Featured Releases

Got News to Share? · Submit · See All

Published on March 25, 2025 - 11:00 GMT

NMD Pharma presents preclinical data highlighting increased innervation of skeletal muscle with ClC-1 ion channel ...

Company presented clinical and preclinical data at the MDA Conference last week in Dallas, Texas Oral presentation included data from MuSK-MG rat model depicting increases in muscle function and improvements in the structural integrity of the neuromuscular …

Distribution channels: Media, Advertising & PR, Technology ...
Published on March 25, 2025 - 10:01 GMT

X4 Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Phase 3 4WARD trial in chronic neutropenia now activated at ~90% of targeted trial sites; full enrollment expected in 3Q or 4Q 2025; top-line data anticipated in 2H 2026 4WARD trial protocol refined, increasing confidence in successful outcome 2024 …

Distribution channels:

Published on March 25, 2025 - 06:30 GMT

Alumis and Kaken Pharmaceutical Announce Collaboration and Licensing Agreement for ESK-001 in Dermatology in Japan

- Alumis to receive $40 million in upfront and near-term co-development payments, with potential for approximately $140 million in additional milestone and field option payments, plus tiered royalties on future sales -Deal underscores the commercial …

Distribution channels: Technology ...
Published on March 25, 2025 - 06:00 GMT

NMD Pharma presents preclinical data highlighting increased innervation of skeletal muscle with ClC-1 ion channel ...

Company presented clinical and preclinical data at the MDA Conference last week in Dallas, Texas Oral presentation included data from MuSK-MG rat model depicting increases in muscle function and improvements in the structural integrity of the neuromuscular …

Distribution channels: Media, Advertising & PR, Technology ...

Published on March 25, 2025 - 03:13 GMT

Lawsuit Notice: Investors who hold Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) shares should contact the Shareholders ...

SAN DIEGO, March 24, 2025 (GLOBE NEWSWIRE) -- Shareholders Foundation, Inc. announced that a lawsuit is pending for certain investors in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN). Investors who purchased shares of Regeneron Pharmaceuticals, …

Distribution channels: Consumer Goods, Media, Advertising & PR ...
Published on March 24, 2025 - 13:44 GMT

Peptic Ulcer Drugs Market to Reach USD 54.8 Billion by 2032 – Persistence Market Research

The global peptic ulcer drugs market is set to grow from USD 42.6 Bn in 2025 to USD 54.8 Bn by 2032, registering a CAGR of 3.2% during the forecast period. LOS ANGELES, CA, UNITED STATES, March 24, 2025 /⁨EINPresswire.com⁩/ -- Peptic ulcers are a …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 00:05 GMT

Nxera Pharma’s Partner Tempero Bio Initiates Phase 2 Trial with TMP-301 for Alcohol Use Disorder

Tokyo, Japan and Cambridge, UK, 25 March 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) announces that its partner Tempero Bio, Inc. has initiated a Phase 2 trial of TMP-301, a potent, selective and orally available mGluR5 negative …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on March 24, 2025 - 23:12 GMT

American Botanical Pharmacy - 562180 - 10/30/2018

Product: Biologics Cosmetics Drugs Blood Products Gene Therapy Deodorant Face Paint Antibiotic Resistance Compounding Issue: Topics Premarket Public Awareness Recipient: Recipient Name Dr. Richard Schulze American Botanical Pharmacy 4114 Glencoe Ave Marina …

Distribution channels: Healthcare & Pharmaceuticals Industry

Got news to share? Submit it now.

Load more pharmaceuticals news or search news using your own keywords. There are 796,912,341 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Pharmaceutical Industry News by Country

Pharmaceutical Industry News by U.S. State

Pharmaceutical Industry News Topics

Online News Publications

World News Report

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter

Create RSS Feed

NewsPlugin for WordPress

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire

Events

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 03/19/2025

World Media Directory

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All

Published on March 25, 2025 - 11:30 GMT

Mobility City's Technician Network, the Largest HME Repair & Delivery Network, is Now an Accredited Exemplary Provider

Mobility City's franchise system, with the largest HME repair and delivery Technician Network in the US, is now a CMS approved Exemplary Provider BOCA RATON, FL, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- Mobility City Holdings Inc, …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 11:30 GMT

Foreign Aid Bridge Fund Donations Surpass $1 Million

Emergency Funding Fuels Life-Saving Relief for Frontline Organizations Amid Rising Global Crises WASHINGTON, RI, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- The Foreign Aid Bridge Fund has surpassed $1 million in donations just over a …

Distribution channels: Emergency Services, Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 11:00 GMT

Enkrypt AI Launches New Multimodal AI Security Solution to Safeguard Text, Image, and Voice AI Systems

Innovative solution secures multimodal AI systems from emerging security, bias, and compliance risks BOSTON, MA, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- Enkrypt AI, a leader in AI security and compliance – is proud to announce the …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
Published on March 25, 2025 - 11:00 GMT

Dean Melissa Perry appointed to prestigious National Academies of Sciences, Engineering, and Medicine Committee

Perry appointed to NASEM Committee on Clinical Follow-Up and Care for Those Impacted by the JP-5 Releases at Red Hill. FAIRFAX, VA, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- As a widely respected researcher and public health leader, …

Distribution channels: Education, Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 11:00 GMT

LarmorBio Announces Addition of Multiple New Board Members and Senior Executive Hires

Company Prepares to Scale Business with Proprietary Microscale Magnetic Resonance Technology BOSTON, MA, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- LarmorBio, a Massachusetts Institute of Technology (MIT) start-up pioneering the use of …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 11:00 GMT

CMTA’s $300K Investment in CRISPR for CMT2A

CMTA invests $300K in CRISPR gene editing for CMT2A at UCSF’s Gladstone Institutes, targeting MFN2 mutations to restore nerve function. GLENOLDEN, PA, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- The Charcot-Marie-Tooth Association (CMTA …

Distribution channels: Education, Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 10:45 GMT

Feroot Launches PaymentGuard AI: Automated PCI DSS 4 Compliance for Websites with E-commerce Payment Webpages.

PaymentGuard AI by Feroot Security: Automating PCI DSS 4 Compliance with Requirements 6.4.3 and 11.6.1 for SAQ D and SAQ A-EP E-Commerce Merchants. TORONTO, CANADA, March 25, 2025 /⁨EINPresswire.com⁩/ -- Feroot Security, a leader in cybersecurity …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 10:45 GMT

PUSH for Empowered Pregnancy Launches #MomentForStillness to Honor Babies Born Still and Demand Urgent Action

A Nationwide Call to Address Preventable Stillbirths Begins March 25th at Noon ET NEW YORK, NY, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- PUSH for Empowered Pregnancy is launching the #MomentForStillness campaign at noon ET on Tuesday, …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 10:18 GMT

TravelingWiki Foundation Launches 'Card For a Cause' to Leverage Sports Cards for Free Non Visible Disability Resources

TravelingWiki Now Offers Free Resources in English, Spanish, French, German, Mandarin, Japanese, Hebrew, Arabic, Portuguese, Hindi, Twi, Vietnamese & Russian DES MOINES, IA, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- TravelingWiki …

Distribution channels: Aviation & Aerospace Industry, Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 10:00 GMT

PhenoBiome Welcomes New Leadership and Validates Breakthrough Microbiome Modulation

Brian Russon Named CEO, Kait Mikes Appointed COO as Company Advances Clinical Validation of Predictive Platform PALM SPRINGS, CA, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- PhenoBiome, Inc., a pioneering leader in personalized …

Distribution channels: Business & Economy, Food & Beverage Industry ...
Published on March 25, 2025 - 09:45 GMT

Florida Mesothelioma Victims Center Has Endorsed the Gori Law Firm for a Former Power Plant Worker with Just Diagnosed ...

TAMPA , FL, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- The Florida Mesothelioma Victims Center says, "We have endorsed, and we highly recommend the Gori Law Firm for a former power plant worker with just diagnosed mesothelioma or …

Distribution channels: Automotive Industry, Building & Construction Industry ...
Published on March 25, 2025 - 09:43 GMT

OmnySense to Target Oncology Patients as Initial Focus for Its Transformative Personal Health-Assessment Solution

19m Americans have cancer. Unplanned acute visits drive nearly half the costs-creating a major unmet need and opportunity for innovative solutions TEL AVIV, ISRAEL, March 25, 2025 /⁨EINPresswire.com⁩/ -- OmnySense, an innovative digital health …

Distribution channels: Banking, Finance & Investment Industry, Emergency Services ...
Published on March 25, 2025 - 08:17 GMT

RSU Research Week Opening Session highlights the interaction between medicine, technology, and behavioural science

RSU Research Week 2025 opened on 24 March with an ambitious plenary session focusing on the role of research, technology, and the human factor in healthcare. RIGA, LATVIA, March 25, 2025 /⁨EINPresswire.com⁩/ -- RSU Research Week 2025 opened on 24 …

Distribution channels: Education, Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 08:09 GMT

Dan Pitulia Appointed as Group CEO of the Atlas Antibodies Group

The Board of Atlas Antibodies Group is pleased to announce the appointment of Dan Pitulia as the new Group Chief Executive Officer (CEO). STOCKHOLM, SWEDEN, March 25, 2025 /⁨EINPresswire.com⁩/ -- The Board of Atlas Antibodies Group is pleased to announce …

Distribution channels: Business & Economy, Chemical Industry ...
Published on March 25, 2025 - 07:36 GMT

A' Wellness, Health Promotion, and Preventive Care Design Award Announces Comprehensive Prize Package for 2024

The prestigious A' Wellness, Health Promotion, and Preventive Care Design Award reveals an extensive array of benefits for 2024 competition laureates COMO, CO, ITALY, March 25, 2025 /⁨EINPresswire.com⁩/ -- The A' Wellness, Health Promotion …

Distribution channels: Business & Economy, Consumer Goods ...
Published on March 25, 2025 - 05:24 GMT

Unlocking the Potential of Tofacitinib: New Frontiers in Treating Skin Disorders

BRADENTON, FL, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- Skin disease related to immune system problems can be a challenge to treat. A new drug, Tofacitinib has gained attention for its therapeutic effects in autoimmune and inflammatory …

Distribution channels: Beauty & Hair Care, Education ...
Published on March 25, 2025 - 05:08 GMT

Acclaim Autism Opens New Early Childhood ABA Therapy Center in Lancaster, PA

Acclaim Autism Opens New Early Childhood ABA Therapy Center in Lancaster, PA: Empowering young children with autism through individualized therapy. LANCASTER, PA, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- Acclaim Autism is thrilled to …

Distribution channels: Education, Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 11:30 GMT

Cognition Therapeutics to Report Biomarker Results from Phase 2 SHINE Study in Mild-to-Moderate Alzheimer’s Disease in ...

PURCHASE, N.Y., March 25, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, will be presenting biomarker results from the …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 11:30 GMT

Enable Injections Announces Regulatory CE Mark Approval in Europe for enFuse Technology

CINCINNATI, March 25, 2025 (GLOBE NEWSWIRE) -- Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing the enFuse® wearable drug delivery platform, today announced it has received its European Union Medical Device …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on March 25, 2025 - 11:30 GMT

CorMedix Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

‒ Q4 2024 Net Revenue of $31.2mm; 2024 Net Revenue of $43.5mm ‒ ‒ Q4 Net Income of $13.5mm and Adjusted EBITDA of $15.3mm ‒ ‒ Conference Call Scheduled for Today at 8:30 a.m. Eastern Time ‒ BERKELEY HEIGHTS, N.J., March 25, 2025 (GLOBE NEWSWIRE) -- …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...